Traditional small ganja farmers in Jamaica, accustomed to clandestinely working their fields, will now have to adhere to strict regulations in order to supply research institutions that have been granted licences.
Cannabis stocks proved lucrative at the beginning of 2014, but the chances of a solid return deteriorated in the second half of the year. An investor who pumped money into a mix of securities followed by the Viridian Cannabis Stock Index in early January of last year could’ve netted a 938% return at the end of the first quarter. That equates to a profit of nearly $94,000 on an initial investment of $10,000. But a similar investment made in the second quarter would’ve only netted an investor $283 in profits. From there, the chances of a loss increased dramatically.
Executive Chairman of Medicanja, Dr Henry Lowe, is urging a spirit of cooperation between government ministries and agencies involved in the development of Jamaica's ganja industry, following the passage of the Decriminalisation Bill.
Despite strong ministerial and legislative signals, segments of the marijuana lobby are unsure that sufficient protections will be afforded to the persons who currently supply the raw material. The challe
A new report predicts that 18 U.S. states will have legalized recreational marijuana in the next five years, a huge increase from the four states that currently have or are in the process of creating legal markets for pot.
Marijuana policy may not seem like the natural setting to model policies that pursue inclusive growth, but the innovative policy-making processes initiated in four US states are actually well worth considering.
Since 2001, Canada has allowed patients to grow their own marijuana or designate a grower to do so on their behalf, but a policy change established the opportunity for licensed growers operating under strict quality controls to supply patients – essentially spawning a new legal marijuana industry overnight.
The vaping trend seemingly knows no bounds as the first “cannabis” e-cigarette goes on sale in the UK. The KanaVape, which contains hemp, has been legalised for use in France by people with cancer, multiple sclerosis (MS) and other conditions requiring pain relief. It will go on sale around the world tomorrow but the Home Office has cast doubt on whether that would be legal, saying the product must be tested for controlled substances. KanaVape cannot be compared to a joint because it does not contain THC, the chemical causing cannabis highs.
France has sought to stamp out a new electronic cigarette containing cannabis, launched with the claim that it provides all of the relaxation but none of the mind-altering effects of the drug. The health minister, Marisol Touraine, said the product would incite the consumption of cannabis and she intended to approach the courts to ban it. “I am opposed to such a product being commercialised in France,” she told RTL radio. The product was launched by a French-Czech company called Kanavape which said it hoped to offer millions of people a legal and flavourful way to consume cannabis.
The legal weed industry is trying to grow something else these days: political influence. The National Cannabis Industry Association has spent $60,000 lobbying Congress and federal regulators during the first nine months of this year — double its lobbying expenses for all of 2013. Its political action committee also shelled out campaign money to help politicians in tough midterm races, including Democratic Gov. John Hickenlooper of Colorado, where voters in 2012 approved the recreational use of marijuana.
Last week, NBC’s Today Show giddily announced an exclusive: Privateer Holdings, the Seattle marijuana company long acclaimed locally for its straight, corporate image and Ivy-League-educated bosses, was launching “the first global pot brand” based on the legacy of Bob Marley. The company is likely to start selling pot overseas, says Privateer public-relations director Zack Hutson, previously a spokesperson for Starbucks. “We’re in discussions with a distributor in Israel” – a country with a federally legal medical-marijuana system. Hutson also cites Uruguay and the Netherlands as potential early markets.